Latest / Weekly Neurology Deep Dive - A review of recent impactful publications in the field of Neurology
Rituximab Use in Anti-NMDAR Antibody-Mediated Encephalitis Relapse Prevention
This multicenter cohort study investigated the effectiveness of rituximab in preventing relapses in adult patients diagnosed with anti-NMDAR antibody-mediated encephalitis. Researchers evaluated the impact of a single course of rituximab on the time to first relapse and explored the duration of its effect, specifically at six and twelve months following treatment. The findings suggest that a single rituximab course is associated with a reduced risk of relapse, with the protective effect lasting for approximately six months. These results highlight the potential benefit of rituximab in…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.